Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.

Kasikara C, Davra V, Calianese D, Geng K, Spires TE, Quigley M, Wichroski M, Sriram G, Suarez-Lopez L, Yaffe MB, Kotenko SV, De Lorenzo MS, Birge RB.

Cancer Res. 2019 May 15;79(10):2669-2683. doi: 10.1158/0008-5472.CAN-18-2614. Epub 2019 Mar 15.

PMID:
30877108
2.

Sterile particle-induced inflammation is mediated by macrophages releasing IL-33 through a Bruton's tyrosine kinase-dependent pathway.

Mishra PK, Palma M, Buechel B, Moore J, Davra V, Chu N, Millman A, Hallab NJ, Kanneganti TD, Birge RB, Behrens EM, Rivera A, Beebe KS, Benevenia J, Gause WC.

Nat Mater. 2019 Mar;18(3):289-297. doi: 10.1038/s41563-018-0271-6. Epub 2019 Jan 21.

3.

Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.

Zhou J, Yang A, Wang Y, Chen F, Zhao Z, Davra V, Suzuki-Inoue K, Ozaki Y, Birge RB, Lu Q, Wu Y.

Cell Commun Signal. 2018 Dec 12;16(1):98. doi: 10.1186/s12964-018-0308-0.

4.

ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.

DaSilva-Arnold SC, Kuo CY, Davra V, Remache Y, Kim PCW, Fisher JP, Zamudio S, Al-Khan A, Birge RB, Illsley NP.

Mol Hum Reprod. 2019 Feb 1;25(2):61-75. doi: 10.1093/molehr/gay053.

5.

Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.

Obr AE, Kumar S, Chang YJ, Bulatowicz JJ, Barnes BJ, Birge RB, Lazzarino DA, Gallagher E, LeRoith D, Wood TL.

Breast Cancer Res. 2018 Nov 20;20(1):138. doi: 10.1186/s13058-018-1063-2.

6.

MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity.

Cai B, Kasikara C, Doran AC, Ramakrishnan R, Birge RB, Tabas I.

Sci Signal. 2018 Sep 25;11(549). pii: eaar3721. doi: 10.1126/scisignal.aar3721.

7.

International conference on Cell Death in Cancer and Toxicology 2018 (CDCT-2018).

Ansari KM, Arany PR, Arama E, Larisch S, Birge RB, Chandra D.

Cell Commun Signal. 2018 Jun 28;16(1):34. doi: 10.1186/s12964-018-0238-x.

8.

Light Harvesting by Equally Contributing Mechanisms in a Photosynthetic Antenna Protein.

Guberman-Pfeffer MJ, Greco JA, Birge RR, Frank HA, Gascón JA.

J Phys Chem Lett. 2018 Feb 1;9(3):563-568. doi: 10.1021/acs.jpclett.7b03211. Epub 2018 Jan 19.

PMID:
29337581
9.

Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer.

Kumar S, Davra V, Obr AE, Geng K, Wood TL, De Lorenzo MS, Birge RB.

Oncoimmunology. 2017 Sep 27;7(1):e1376155. doi: 10.1080/2162402X.2017.1376155. eCollection 2017. Erratum in: Oncoimmunology. 2017 Dec 19;7(1):e1413845.

10.

The Forbidden 11Bu- Excited Singlet State in Peridinin and Peridinin Analogues.

Greco JA, Wagner NL, Frank HA, Birge RR.

J Phys Chem A. 2018 Jan 11;122(1):130-139. doi: 10.1021/acs.jpca.7b10001. Epub 2017 Dec 19.

PMID:
29202230
11.

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6.

Geng K, Kumar S, Kimani SG, Kholodovych V, Kasikara C, Mizuno K, Sandiford O, Rameshwar P, Kotenko SV, Birge RB.

Front Immunol. 2017 Nov 10;8:1521. doi: 10.3389/fimmu.2017.01521. eCollection 2017.

12.

Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment.

Kumar S, Calianese D, Birge RB.

Immunol Rev. 2017 Nov;280(1):149-164. doi: 10.1111/imr.12587. Review.

PMID:
29027226
13.

The Procoagulant Activity of Apoptotic Cells Is Mediated by Interaction with Factor XII.

Yang A, Chen F, He C, Zhou J, Lu Y, Dai J, Birge RB, Wu Y.

Front Immunol. 2017 Sep 25;8:1188. doi: 10.3389/fimmu.2017.01188. eCollection 2017.

14.

Crk Tyrosine Phosphorylation Regulates PDGF-BB-inducible Src Activation and Breast Tumorigenicity and Metastasis.

Kumar S, Lu B, Davra V, Hornbeck P, Machida K, Birge RB.

Mol Cancer Res. 2018 Jan;16(1):173-183. doi: 10.1158/1541-7786.MCR-17-0242. Epub 2017 Oct 3.

15.

Expression, purification, and spectral tuning of RhoGC, a retinylidene/guanylyl cyclase fusion protein and optogenetics tool from the aquatic fungus Blastocladiella emersonii.

Trieu MM, Devine EL, Lamarche LB, Ammerman AE, Greco JA, Birge RR, Theobald DL, Oprian DD.

J Biol Chem. 2017 Jun 23;292(25):10379-10389. doi: 10.1074/jbc.M117.789636. Epub 2017 May 4.

16.

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.

Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, Comollo T, Peng Y, Kotenko SV, Sarafianos SG, Bertino JR, Welsh WJ, Birge RB.

Sci Rep. 2017 Mar 8;7:43908. doi: 10.1038/srep43908.

17.

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.

Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, Sriram G, Devoe C, Nguyen KN, Antes A, Krantz A, Rymarczyk G, Wilczynski A, Empig C, Freimark B, Gray M, Schlunegger K, Hutchins J, Kotenko SV, Birge RB.

Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9.

18.

Bacteriochlorins with a Twist: Discovery of a Unique Mechanism to Red-Shift the Optical Spectra of Bacteriochlorins.

Guberman-Pfeffer MJ, Greco JA, Samankumara LP, Zeller M, Birge RR, Gascón JA, Brückner C.

J Am Chem Soc. 2017 Jan 11;139(1):548-560. doi: 10.1021/jacs.6b12419. Epub 2016 Dec 20.

PMID:
27997161
19.

Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response.

Davra V, Kimani SG, Calianese D, Birge RB.

Cancers (Basel). 2016 Nov 29;8(12). pii: E107. Review.

20.

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.

Kimani SG, Kumar S, Davra V, Chang YJ, Kasikara C, Geng K, Tsou WI, Wang S, Hoque M, Boháč A, Lewis-Antes A, De Lorenzo MS, Kotenko SV, Birge RB.

Cell Commun Signal. 2016 Sep 6;14(1):19. doi: 10.1186/s12964-016-0142-1.

21.

Efferocytosis.

Kumar S, Birge RB.

Curr Biol. 2016 Jul 11;26(13):R558-R559. doi: 10.1016/j.cub.2016.01.059.

22.

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.

Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, Barcinski M, Brekken RA, Huang X, Hutchins JT, Freimark B, Empig C, Mercer J, Schroit AJ, Schett G, Herrmann M.

Cell Death Differ. 2016 Jun;23(6):962-78. doi: 10.1038/cdd.2016.11. Epub 2016 Feb 26. Review.

23.

Spectroscopic Investigation of the Carotenoid Deoxyperidinin: Direct Observation of the Forbidden S0 → S1 Transition.

Greco JA, LaFountain AM, Kinashi N, Shinada T, Sakaguchi K, Katsumura S, Magdaong NC, Niedzwiedzki DM, Birge RR, Frank HA.

J Phys Chem B. 2016 Mar 17;120(10):2731-44. doi: 10.1021/acs.jpcb.6b00439. Epub 2016 Mar 4.

PMID:
26907520
24.

Effects of Strong Electronic Coupling in Chlorin and Bacteriochlorin Dyads.

Kang HS, Esemoto NN, Diers JR, Niedzwiedzki DM, Greco JA, Akhigbe J, Yu Z, Pancholi C, Bhagavathy GV, Nguyen JK, Kirmaier C, Birge RR, Ptaszek M, Holten D, Bocian DF.

J Phys Chem A. 2016 Jan 28;120(3):379-95. doi: 10.1021/acs.jpca.5b10686. Epub 2016 Jan 14.

PMID:
26765839
25.

Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.

Saleh T, Jankowski W, Sriram G, Rossi P, Shah S, Lee KB, Cruz LA, Rodriguez AJ, Birge RB, Kalodimos CG.

Nat Chem Biol. 2016 Feb;12(2):117-23. doi: 10.1038/nchembio.1981. Epub 2015 Dec 14.

26.

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.

Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, Dudek-Peric AM, Faggioni A, Fucikova J, Gaipl US, Golab J, Gougeon ML, Hamblin MR, Hemminki A, Herrmann M, Hodge JW, Kepp O, Kroemer G, Krysko DV, Land WG, Madeo F, Manfredi AA, Mattarollo SR, Maueroder C, Merendino N, Multhoff G, Pabst T, Ricci JE, Riganti C, Romano E, Rufo N, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Vacchelli E, Vandenabeele P, Vandenberk L, Van den Eynde BJ, Van Gool S, Velotti F, Zitvogel L, Agostinis P.

Front Immunol. 2015 Nov 20;6:588. doi: 10.3389/fimmu.2015.00588. eCollection 2015.

27.

Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.

Kumar S, Lu B, Dixit U, Hossain S, Liu Y, Li J, Hornbeck P, Zheng W, Sowalsky AG, Kotula L, Birge RB.

Oncotarget. 2015 Nov 10;6(35):37792-807. doi: 10.18632/oncotarget.6096.

28.

Low-Temperature Trapping of Photointermediates of the Rhodopsin E181Q Mutant.

Sandberg MN, Greco JA, Wagner NL, Amora TL, Ramos LA, Chen MH, Knox BE, Birge RR.

SOJ Biochem. 2014;1(1). pii: 12.

29.

Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity.

Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y, Birge RB.

Front Immunol. 2014 Nov 10;5:566. doi: 10.3389/fimmu.2014.00566. eCollection 2014. Review.

30.

Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.

Sriram G, Jankowski W, Kasikara C, Reichman C, Saleh T, Nguyen KQ, Li J, Hornbeck P, Machida K, Liu T, Li H, Kalodimos CG, Birge RB.

Oncogene. 2015 Aug 6;34(32):4260-9. doi: 10.1038/onc.2014.361. Epub 2014 Nov 10.

31.

High efficiency light harvesting by carotenoids in the LH2 complex from photosynthetic bacteria: unique adaptation to growth under low-light conditions.

Magdaong NM, LaFountain AM, Greco JA, Gardiner AT, Carey AM, Cogdell RJ, Gibson GN, Birge RR, Frank HA.

J Phys Chem B. 2014 Sep 25;118(38):11172-89. doi: 10.1021/jp5070984. Epub 2014 Sep 11.

32.

Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.

Nguyen KQ, Tsou WI, Calarese DA, Kimani SG, Singh S, Hsieh S, Liu Y, Lu B, Wu Y, Garforth SJ, Almo SC, Kotenko SV, Birge RB.

J Biol Chem. 2014 Sep 12;289(37):25737-49. doi: 10.1074/jbc.M114.570838. Epub 2014 Jul 29.

33.

Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.

Tsou WI, Nguyen KQ, Calarese DA, Garforth SJ, Antes AL, Smirnov SV, Almo SC, Birge RB, Kotenko SV.

J Biol Chem. 2014 Sep 12;289(37):25750-63. doi: 10.1074/jbc.M114.569020. Epub 2014 Jul 29.

34.

High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.

Yang A, Dai J, Xie Z, Colman RW, Wu Q, Birge RB, Wu Y.

J Immunol. 2014 May 1;192(9):4398-408. doi: 10.4049/jimmunol.1302590. Epub 2014 Mar 31.

35.

Excited state properties of a short π-electron conjugated peridinin analogue.

Magdaong NM, Niedzwiedzki DM, Greco JA, Liu H, Yano K, Kajikawa T, Sakaguchi K, Katsumura S, Birge RR, Frank HA.

Chem Phys Lett. 2014 Feb 11;593:132-139.

36.

Photochromic bacteriorhodopsin mutant with high holographic efficiency and enhanced stability via a putative self-repair mechanism.

Ranaghan MJ, Greco JA, Wagner NL, Grewal R, Rangarajan R, Koscielecki JF, Wise KJ, Birge RR.

ACS Appl Mater Interfaces. 2014 Feb 26;6(4):2799-808. doi: 10.1021/am405363z. Epub 2014 Feb 14.

37.

Crk at the quarter century mark: perspectives in signaling and cancer.

Kumar S, Fajardo JE, Birge RB, Sriram G.

J Cell Biochem. 2014 May;115(5):819-25. doi: 10.1002/jcb.24749.

PMID:
24356912
38.

A spectroscopic and theoretical investigation of a free-base meso-trithienylcorrole.

Greco JA, Rossi A, Birge RR, Brückner C.

Photochem Photobiol. 2014 Mar-Apr;90(2):402-14. doi: 10.1111/php.12203. Epub 2013 Dec 5.

39.

A conserved aromatic residue regulating photosensitivity in short-wavelength sensitive cone visual pigments.

Kuemmel CM, Sandberg MN, Birge RR, Knox BE.

Biochemistry. 2013 Jul 30;52(30):5084-91. doi: 10.1021/bi400490g. Epub 2013 Jul 16.

PMID:
23808485
40.

Directed evolution of bacteriorhodopsin for applications in bioelectronics.

Wagner NL, Greco JA, Ranaghan MJ, Birge RR.

J R Soc Interface. 2013 May 15;10(84):20130197. doi: 10.1098/rsif.2013.0197. Print 2013 Jul 6.

41.

TAM receptors in apoptotic cell clearance, autoimmunity, and cancer.

Nguyen KQ, Tsou WI, Kotenko S, Birge RB.

Autoimmunity. 2013 Aug;46(5):294-7. doi: 10.3109/08916934.2013.794515. Epub 2013 May 10. Review.

PMID:
23662598
42.

The nature of the intramolecular charge transfer state in peridinin.

Wagner NL, Greco JA, Enriquez MM, Frank HA, Birge RR.

Biophys J. 2013 Mar 19;104(6):1314-25. doi: 10.1016/j.bpj.2013.01.045. Epub 2013 Mar 19.

43.

ATG proteins mediate efferocytosis and suppress inflammation in mammary involution.

Teplova I, Lozy F, Price S, Singh S, Barnard N, Cardiff RD, Birge RB, Karantza V.

Autophagy. 2013 Apr;9(4):459-75. doi: 10.4161/auto.23164. Epub 2013 Feb 4.

44.

Energetics and dynamics of the low-lying electronic states of constrained polyenes: implications for infinite polyenes.

Christensen RL, Enriquez MM, Wagner NL, Peacock-Villada AY, Scriban C, Schrock RR, Polívka T, Frank HA, Birge RR.

J Phys Chem A. 2013 Feb 21;117(7):1449-65. doi: 10.1021/jp310592s. Epub 2013 Feb 5.

45.

Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.

Hossain S, Dubielecka PM, Sikorski AF, Birge RB, Kotula L.

Genes Cancer. 2012 May;3(5-6):402-13. doi: 10.1177/1947601912460051.

46.

Monographs editor.

Birge RB.

Genes Cancer. 2012 May;3(5-6):331. doi: 10.1177/1947601912460548. No abstract available.

47.

Effect of Molecular Symmetry on the Spectra and Dynamics of the Intramolecular Charge Transfer (ICT) state of peridinin.

Enriquez MM, Hananoki S, Hasegawa S, Kajikawa T, Katsumura S, Wagner NL, Birge RR, Frank HA.

J Phys Chem B. 2012 Sep 6;116(35):10748-56. doi: 10.1021/jp305804q. Epub 2012 Aug 28.

48.

meso-arylporpholactones and their reduction products.

Brückner C, Ogikubo J, McCarthy JR, Akhigbe J, Hyland MA, Daddario P, Worlinsky JL, Zeller M, Engle JT, Ziegler CJ, Ranaghan MJ, Sandberg MN, Birge RR.

J Org Chem. 2012 Aug 3;77(15):6480-94. doi: 10.1021/jo300963m. Epub 2012 Jul 19.

49.

Commentary: The carboxyl-terminal Crk SH3 domain: Regulatory strategies and new perspectives.

Sriram G, Birge RB.

FEBS Lett. 2012 Aug 14;586(17):2615-8. doi: 10.1016/j.febslet.2012.04.040. Epub 2012 May 2. Review.

50.

Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.

Jankowski W, Saleh T, Pai MT, Sriram G, Birge RB, Kalodimos CG.

Nat Chem Biol. 2012 May 13;8(6):590-6. doi: 10.1038/nchembio.954.

Supplemental Content

Support Center